Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederinvestor.lilly.com
Eli Lilly and Company News Releases
Get the latest updates from Eli Lilly and Company News Releases directly as they happen.
Follow now 223 followers
Latest posts
Last updated 1 day ago
Lilly Confirms Date and Conference Call for Second-Quarter 2024 Financial Results Announcement
1 day ago
INDIANAPOLIS , July 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
19 days ago
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies INDIANAPOLIS and...
Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease
24 days ago
Kisunla slowed cognitive and functional decline by up to 35% compared to...
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria
about 1 month ago
INDIANAPOLIS , June 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...
Lilly Declares Third-Quarter 2024 Dividend
about 1 month ago
INDIANAPOLIS , June 24, 2024 /PRNewswire/ -- The board of directors of...
Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution
about 1 month ago
In the primary endpoint, tirzepatide reduced moderate-to-severe OSA severity by up to...
Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products
about 1 month ago
Eli Lilly and Company is committed to meeting the needs of people...
An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®
about 1 month ago
Lilly is committed to making life better for people living with diabetes...
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks
about 2 months ago
SYNERGY-NASH results were presented at the European Association for the Study of...
Lilly announces departure of Anat Ashkenazi, chief financial officer
about 2 months ago
INDIANAPOLIS , June 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...
Melissa Seymour to join Lilly as executive vice president of Global Quality
about 2 months ago
INDIANAPOLIS , June 4, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting
about 2 months ago
Data demonstrated promising monotherapy activity with olomorasib across a range of KRAS...